Showing results (61-70 of 84) with videos related to
Sort By:
Pageof 9
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 12, 2022
The Diagnostic Utility of IDH2 R172 Immunohistochemistry in Tall Cell Carcinoma With Reversed Polarity of the BreastEiichi Sasaki, Akari Iwakoshi, Tatsunari Satake, et al.Cancer Genetics|October 10, 2025
Identification of novel gene fusions in high-grade serous ovarian carcinoma: implications for tumorigenesis and targeted therapyKatsuhiro Masago, Eiichi Sasaki, Yasuko Fujita, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2020
Novel Resistance Mechanisms Including L1196Q, P1094H, and R1248_D1249 Insertion in Three Patients With NSCLC After ALK Tyrosine Kinase Inhibitor TreatmentHiromi Furuta, Mitsugu Araki, Katsuhiro Masago, et al.Annals of Surgical Oncology|February 8, 2023
The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy may Predict Pathological Complete Response with High Accuracy: Results from a Phase II TrialAyumi Kataoka, Masataka Sawaki, Nanae Horisawa, et al.Pathology International|January 24, 2020
Negative reactions of BRAF mutation-specific immunohistochemistry to non-V600E mutations of BRAFKatsutoshi Seto, Masataka Haneda, Katsuhiro Masago, et al.Cancer Genetics|May 22, 2022
Sensitivity to dabrafenib and trametinib treatments in patients with non-small-cell cancer harboring BRAF compound mutations: A pooled analysis of BRAF p.V600E-positive advanced non-small-cell lung cancerKatsutoshi Seto, Junichi Shimizu, Katsuhiro Masago, et al.Thoracic Cancer|December 17, 2025
Salvage Surgery Following Systemic Therapy in Initially Unresectable Non-Small Cell Lung CancerKatsutoshi Seto, Yoshitsugu Horio, Katsuhiro Masago, et al.Molecular Cancer Therapeutics|December 20, 2014
Combining onartuzumab with erlotinib inhibits growth of non-small cell lung cancer with activating EGFR mutations and HGF overexpressionYuji Sano, Eri Hashimoto, Noriaki Nakatani, et al.Cancer Genetics|March 23, 2025
Immune prognostic model for glioblastoma based on the ssGSEA enrichment scoreTakanari Okamoto, Ryo Mizuta, Ayako Demachi-Okamura, et al.The Journal of Pathology|May 3, 2025
Clinicopathological and molecular characterization of KRAS wild-type pancreatic ductal adenocarcinomas reveals precursor lesions with oncogenic mutations and fusions in RAS pathway genesKazuhiro Toriyama, Katsuhiro Masago, Noriko Shibata, et al.Pageof 9